TroyGould Attorneys Sign TroyGould Attorneys Sign

TroyGould client acquired for $359 million

On August 1, 2017, Repligen Corporation, a Nasdaq listed life sciences company, acquired privately-held Spectrum, Inc. in a merger transaction for approximately $359 million, comprised of $120 million in cash plus 6,154,000 shares of Repligen stock.  Spectrum is a diversified filtration company with a differentiated portfolio of hollow fiber cartridges, bench-top to commercial scale filtration and perfusion systems and an expansive portfolio of single-use solutions. Spectrum’s products are used for the filtration, isolation, purification and concentration of monoclonal antibodies, vaccines, recombinant proteins, diagnostic products and cell therapies.

TroyGould represented Spectrum, Inc. The TroyGould team included Members Dale Short, Istvan Benko and Sandy Slon, and associates Christian Hollweg and Dietrick Miller.